InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
5
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+21.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Grossman Jerrold B, Director. Officer active across 1 company, notably Adma Biologics, INC.. Cumulatively, 13 disclosures have been published. Split: 5 buys · 1 sell. Total volume traded: €927k. Activity tracked since 25 October 2021. The latest transaction was filed on 27 May 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Grossman Jerrold B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
6,400 shares@ US$7.910.0023% mcap2.8% of flowCommon StockSEC:0001140361-26-023127:0
Canonical exit: 25 Aug 2026 (T+90)
12,500 shares@ US$8.010.0045% mcap24.9% of flowCommon StockSEC:0001140361-26-021150:0
Canonical exit: 10 Aug 2026 (T+90)
12,500 shares@ US$8.010.0044% mcap5.5% of flowCommon StockSEC:0001140361-26-020855:0
Canonical exit: 9 Aug 2026 (T+90)
10,690 shares0Common StockSEC:0001140361-26-004892:0
10,000 shares@ US$5.002.8% of flowCommon StockSEC:0001140361-25-022113:0
10,000 shares@ US$21.3112.1% of flowCommon StockSEC:0001140361-25-022113:1
10,889 shares0Common StockSEC:0001140361-25-005538:0
118,861 shares@ US$3.6625.6% of flowCommon StockSEC:0001140361-24-039821:0
24,040 shares0Common StockSEC:0001140361-24-010241:0
130,000 shares@ US$3.708828.7% of flowCommon StockSEC:0001140361-23-041848:0
Canonical exit: 28 Nov 2023 (T+90)
25,815 shares0Common StockSEC:0001140361-23-010772:0
26,586 shares0Common StockSEC:0001140361-22-008670:0
100,000 shares@ US$1.000.0045% mcap25.1% of flowCommon StockSEC:0001140361-21-035381:0
Canonical exit: 23 Jan 2022 (T+90)
13 of 13 declarations
About Grossman Jerrold B
Grossman Jerrold B is a Board Member at ADMA BIOLOGICS, INC. He contributes to the governance and strategy of the company, bringing his expertise in leadership and decision-making.
